Spermatogenesis promotion

Spermatogenesis promotion refers to the physiological process and therapeutic goal of inducing or enhancing the production of mature sperm cells within the testes. This process is not a single molecular target but a complex sequence of germ cell differentiation and maturation regulated by the hypothalamic-pituitary-gonadal (HPG) axis. In a clinical context, promoting spermatogenesis is the primary intervention for male infertility, particularly for patients with hypogonadotropic hypogonadism or idiopathic oligozoospermia. Pharmacological agents achieve this effect by mimicking or stimulating the action of gonadotropins, such as Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). These drugs interact with specific molecular targets like the Follicle-Stimulating Hormone Receptor (FSHR) on Sertoli cells and the Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR) on Leydig cells. Additionally, selective estrogen receptor modulators (SERMs) may be used to increase endogenous gonadotropin production by blocking negative feedback at the hypothalamus and pituitary. Successful spermatogenesis promotion is monitored through semen analysis parameters, including sperm count, motility, and morphology, as well as serum hormone levels.

Other names

Sperm production enhancementInduction of spermatogenesisSpermatogenic stimulation

Promotion of spermatogenesis is achieved by activating the Follicle-Stimulating Hormone Receptor (FSHR) on Sertoli cells and the Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR) on Leydig cells, or by modulating the hypothalamic-pituitary-gonadal axis to increase endogenous gonadotropin secretion.